Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 2 Comparison of underlying diseases and preoperative symptoms between the two groups

From: Efficacy of medical thoracoscopy combined with fibrinolytic therapy in the treatment of complicated parapneumonic effusions and empyema

Group

Sample size (n)

History of tumors (%)

Chronic kidney disease (%)

Chronic airway disease (%)

Diabetes (%)

Medical thoracoscopy group

33

24.2

15.2

24.2

18.2

Traditional treatment group

75

14.7

8.0

16.0

12.0

Statistical value

 

1.449

1.281

1.032

0.732

P value

 

0.229

0.258

0.310

0.392

Group

Sample size (n)

Fever (%)

Cough (%)

Dyspnea (%)

Chest pain (%)

Medical thoracoscopy group

33

100

72.7

54.5

39.4

Traditional treatment group

75

100

78.7

73.3

30.7

Statistical value

 

0.000

0.454

3.693

0.785

P value

 

1.000

0.500

0.055

0.375

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us